CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Treasury Stock	Retained Deficit	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Common stock, beginning balance (in shares) at Mar. 31, 2025		417,218,811
Stockholders' equity, beginning balance at Dec. 31, 2024	$ (1,604,699)	$ 4,147	$ 3,304,466	$ (526,789)	$ (4,327,152)	$ (73,747)	$ 14,376
Treasury stock, beginning balance (in shares) at Dec. 31, 2024				28,822,484
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	34,439				35,335	(1,571)	675
Settlement of stock-based awards (in shares)		2,465,135		734,400
Settlement of stock-based awards	(2,420)	$ 25	(1)	$ (2,444)
Stock-based compensation expense	13,662		13,662
Common stock, ending balance (in shares) at Dec. 31, 2024		414,753,676
Stockholders' equity, ending balance at Mar. 31, 2025	$ (1,559,018)	$ 4,172	3,318,127	$ (529,233)	(4,291,817)	(75,318)	15,051
Treasury stock, ending balance (in shares) at Mar. 31, 2025				29,556,884
Common stock, beginning balance (in shares) at Mar. 31, 2026	395,311,000	427,741,565
Stockholders' equity, beginning balance at Dec. 31, 2025	$ (1,036,494)	$ 4,274	3,351,111	$ (537,197)	(3,802,535)	(66,656)	14,509
Treasury stock, beginning balance (in shares) at Dec. 31, 2025	32,362,000			32,362,434
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive income	$ 7,837				8,116	(604)	325
Settlement of stock-based awards (in shares)		374,924		68,533
Settlement of stock-based awards	(101)	$ 4		$ (105)
Stock-based compensation expense	$ 3,078		3,078
Common stock, ending balance (in shares) at Dec. 31, 2025	395,004,000	427,366,641
Stockholders' equity, ending balance at Mar. 31, 2026	$ (1,025,680)	$ 4,278	$ 3,354,189	$ (537,302)	$ (3,794,419)	$ (67,260)	$ 14,834
Treasury stock, ending balance (in shares) at Mar. 31, 2026	32,431,000			32,430,967